Camurus

News

Camurus is said to be in talks to acquire US partner Braeburn in a deal that would give it control of their product for treating opioid use disorder.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.